Navigating an evolving bribery and corruption compliance regime
A review of the UK Bribery Act could mean pharma needs to adapt to changes in legislation
25th October 2018
Web Exclusives
Employee mental health in the pharma industry
How pharma companies are starting to lead the change in workplace mental health
10th October 2018
Streamlining gene therapy trial oversight
What the proposed changes to the National Institutes of Health Recombinant DNA Advisory Committee mean for patients and drug developers
9th October 2018
Mark of success
Aaron Hudson from SCIEX provides insight on the potential impact of genetic and non-genetic biomarkers for precision medicine
3rd October 2018
Continuous improvement: new approaches to manufacturing
The biopharmaceutical industry is finally embracing a continuous approach to medicine manufacturing, and we’re already experiencing the benefits
24th September 2018
Connecting care
A fully digital NHS should be close to reality, but it’s a challenge that many hospitals are not ready to take on
21st September 2018
Cutting through the noise
Five steps to overcome challenges presented in pharmaceutical sales
20th September 2018
Closing the gap in global trade compliance
In today’s trade environment, efficient screening is virtually impossible without IT support
20th September 2018
NHS strain set to worsen without immigration plan
Why current immigration plans are not adequette to deal with the growing crisis
18th September 2018
Mental health: collaborating to save lives
Mental health is in the public eye like never before, but research and funding is still behind other areas
18th September 2018
The right NOAC for the right patient
An interview with Professor Sylvia Haas on how best to prevent stroke in patients with atrial fibrillation and co-morbidities
13th September 2018
An industry abandoned
EMIG's Leslie Galloway on how the government’s recent actions could destroy pharma in the UK
10th September 2018
Drug price transparency driving healthier supply chains
The push for greater transparency across the industry brings new opportunities for companies to innovate
6th September 2018
European ruling may bring generic Truvada a step closer
Recent rulings on supplementary protection certificates may raise more questions than answers
31st August 2018
